Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Baert

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|September 1, 1978
Antiinflammatory and analgesic diastereoisomeric derivatives of indan-5-acetic acidJ M Teulon, J C Cognacq, F Hertz, et al.
Acta Gastro-Enterologica Belgica|October 1, 2019
Ulcerative colitis treatment : an insight into daily clinical practiceP Bossuyt, F Baert, J L Coenegrachts, et al.
Acta Gastro-Enterologica Belgica|February 24, 2001
Curative management of adenocarcinoma of the oesophagus and oesogastric junction--current recommendations of the Belgian Working GroupJ L Van Laethem, F Baert, M Buset, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2006
Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging studyG D'Haens, D Hommes, L Engels, et al.
Acta Gastro-Enterologica Belgica|June 30, 2015
Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)S Vermeire, E Louis, O Dewit, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitisM De Vos, O Dewit, G D'Haens, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)D Franchimont, M Ferrante, E Louis, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitisN Eleftheriadis, G Lambrecht, G D'Haens, et al.
The American Journal of Gastroenterology|August 13, 1999
Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research GroupJ Belaiche, E Louis, G D'Haens, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumabH Peeters, E Louis, F Baert, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|September 1, 1978
Antiinflammatory and analgesic diastereoisomeric derivatives of indan-5-acetic acidJ M Teulon, J C Cognacq, F Hertz, et al.
Acta Gastro-Enterologica Belgica|October 1, 2019
Ulcerative colitis treatment : an insight into daily clinical practiceP Bossuyt, F Baert, J L Coenegrachts, et al.
Acta Gastro-Enterologica Belgica|February 24, 2001
Curative management of adenocarcinoma of the oesophagus and oesogastric junction--current recommendations of the Belgian Working GroupJ L Van Laethem, F Baert, M Buset, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2006
Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging studyG D'Haens, D Hommes, L Engels, et al.
Acta Gastro-Enterologica Belgica|June 30, 2015
Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)S Vermeire, E Louis, O Dewit, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitisM De Vos, O Dewit, G D'Haens, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)D Franchimont, M Ferrante, E Louis, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitisN Eleftheriadis, G Lambrecht, G D'Haens, et al.
The American Journal of Gastroenterology|August 13, 1999
Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research GroupJ Belaiche, E Louis, G D'Haens, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumabH Peeters, E Louis, F Baert, et al.
Pageof 6